Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Alpha Cognition Inc ACOGF


Primary Symbol: C.ACOG

Healthcare Biotechnology
Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062... see more

CSE:ACOG - Post Discussion

Alpha Cognition Inc > $ACOG Testing Resistance up ~5% On the Day So Far
View:
Post by partystocker on Nov 29, 2021 2:54pm

$ACOG Testing Resistance up ~5% On the Day So Far

Alpha Cognition $ACOG/$ACOG.V is testing support at $1.12 today and I’m looking for a break above the current bearish trend as shares are up ~5% today. The RSI and Stochastic oscillator are currently at low points so I’m expecting an upward swing in prices. 


$ACOG.V is currently working on a gene therapy to treat ALS. The drug, ALPH-0602, is currently in preclinical development and has been patented and received Orphan Drug Designation from the FDA. I’m keeping alerts set for any developments as the right catalyst could send prices of $ACOG skyrocketing.


$ACOG.V is currently trading at $1.11 and the company is valued at $67.03 million.


https://www.alphacognition.com/our-approach/alpha-0602/

 
Be the first to comment on this post
Alpha Cognition Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities